Eribulin Mesylate 43598-0125-11

Package NDC

43598-0125-11

Manufacturer: Dr. Reddys Laboratories Inc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 22, 2026
Listing Expires: December 31, 2027
Application: ANDA217473

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

43598-0125-11Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1 VIAL, SINGLE-DOSE